---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-202850"
form_type: "8-K"
ticker: "RMD"
cik: "0000943819"
company_name: "RESMED INC"
filed_at: "2023-08-03T23:59:59+00:00"
generated_at: "2026-06-12T10:51:03.969955+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# ResMed Q4 FY2023 revenue up 23% to $1.12B; EPS $1.56 GAAP, dividend raised 9% to $0.48

## Summary
- Revenue $1,122.1M +23% YoY; GAAP diluted EPS $1.56 (+17%), non-GAAP $1.60 (+7%).
- Full-year revenue $4,223.0M (+18%); GAAP EPS $6.09 (+15%), non-GAAP $6.44 (+11%).
- Gross margin contracted 210 bps to 55.0% (GAAP) and 200 bps to 55.8% (non-GAAP).
- Quarterly dividend raised 9% to $0.48/share; record Aug 17, payable Sept 21, 2023.

## SEC filing metadata
- accession: 0001193125-23-202850
- form_type: 8-K
- ticker: RMD
- cik: 0000943819
- company_name: RESMED INC
- filed_at: 2023-08-03T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/943819/000119312523202850/0001193125-23-202850-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/943819/000119312523202850/d510491d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-202850
- JSON: https://secwatch.observer/filing/0001193125-23-202850.json
- Plain text: https://secwatch.observer/filing/0001193125-23-202850.txt

## Key facts
- Earnings Releases
  RESMED INC reported fiscal year ended June 30, 2023 results: revenue $4,223.0, net income $897.6, EPS $6.09.
  - Period: fiscal year ended June 30, 2023
  - Revenue: $4,223.0
  - Net income: $897.6
  - EPS: $6.09
  - Result: reported results
  source text: per share $ 1.56 $ 1.33 17 Non-GAAP diluted earnings per share (B) $ 1.60 $ 1.49 7 Twelve Months Ended June 30, 2023 June 30, 2022 % Change Constant Currency (A) Revenue $ 4,223.0 $ 3,578.1 18 % 21 % Gross margin 55.8 % 56.6 % (1 ) Non-GAAP gross margin (B) 56.5 % 57.7 % (2 ) Selling, general, and administrative expenses 874.0 737.5 19 22 Research and
  evidence_url: https://www.sec.gov/Archives/edgar/data/943819/000119312523202850/0001193125-23-202850-index.htm
- Earnings Releases
  RESMED INC reported the quarter ended June 30, 2023 results: revenue $1,122.1, net income $229.7, EPS $1.56.
  - Period: the quarter ended June 30, 2023
  - Revenue: $1,122.1
  - Net income: $229.7
  - EPS: $1.56
  - Result: reported results
  source text: Results and Operating Metrics Unaudited; $ in millions, except for per share amounts Three Months Ended June 30, 2023 June 30, 2022 % Change Constant Currency (A) Revenue $ 1,122.1 $ 914.7 23 % 23 % Gross margin 55.0 % 57.1 % (4 ) Non-GAAP gross margin (B) 55.8 % 57.8 % (4 ) Selling, general, and administrative expenses 240.7 193.0 25 26 Research and
  evidence_url: https://www.sec.gov/Archives/edgar/data/943819/000119312523202850/0001193125-23-202850-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.